Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02551055
Title MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Advanced Solid Tumor

Therapies

Docetaxel

Paclitaxel

Alisertib

Mivavotinib

MLN1117

Age Groups: adult
Covered Countries USA


No variant requirements are available.